Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | Mobile-health Network Solutions - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
Fr | Mobile-Health Network Solutions kündigt Ausnahmen von Nasdaq-Regeln an | 2 | Investing.com Deutsch | ||
Fr | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
Do | Mobile-health Network Solutions announces share repurchase program of 214,000 shares | 2 | Seeking Alpha | ||
MOBILE-HEALTH NETWORK SOLUTIONS Aktie jetzt für 0€ handeln | |||||
Do | MNDR announces share repurchase program to boost value | 2 | Investing.com | ||
Do | Mobile-health Network Solutions Announces Share Repurchase Program of up to 214,000 Shares | 128 | Newsfile | Singapore, Singapore--(Newsfile Corp. - June 5, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth... ► Artikel lesen | |
22.05. | Mobile-health Network Solutions Signs MOU to Add AI-enabled Dental Scans and Oral Health Screening to its Telemedicine Platform | 273 | Newsfile | Singapore, Singapore--(Newsfile Corp. - May 22, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth... ► Artikel lesen | |
15.05. | Mobile-health Network Solutions to Present at Sidoti Virtual Investor Conference, May 21-22, and Virtual Tech Conference, June 3-5 | 243 | Newsfile | Singapore, Singapore--(Newsfile Corp. - May 15, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth... ► Artikel lesen | |
05.05. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
30.04. | Mobile-health Network Solutions Intends To Acquire Lifepack, Expanding into Indonesia's Growing Healthcare Market | 240 | Newsfile | Singapore, Singapore--(Newsfile Corp. - April 30, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth... ► Artikel lesen | |
29.04. | Mobile-health Network Solutions Wins Cloud-Healthcare Technology Award at SBR Technology Excellence Awards 2025 | 258 | Newsfile | Singapore, Singapore--(Newsfile Corp. - April 29, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth... ► Artikel lesen | |
26.03. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
21.03. | Mobile-health Network Solutions files to sell 3.34M Class A ordinary shares | 2 | Seeking Alpha | ||
21.03. | Mobile-health Network Solutions - F-1, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
06.03. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
27.02. | Centurion One Capital Corp.: Mobile-health Network Solutions to Present at Centurion One Capital 8th Annual Growth Conference | 269 | Newsfile | Singapore, Singapore--(Newsfile Corp. - February 27, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a pioneering MedTech company dedicated to enhancing human connection... ► Artikel lesen | |
19.02. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
04.02. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
17.01. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
26.12.24 | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,111 | 0,00 % | Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy | Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH 02.06.2025 / 13:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group.... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,800 | +8,40 % | Ascendiant Capital raises Atossa Genetics stock price target to $7.50 | ||
PING AN HEALTHCARE | 0,755 | 0,00 % | PA GOODDOCTOR (01833): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING | ||
MOUNTAIN VALLEY MD | 0,012 | -16,44 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
CO-DIAGNOSTICS | 0,274 | +3,01 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
VERU | 0,525 | -3,40 % | Tootsie Roll among names set to join Russell 3000 Index, Growgeneration, Veru set to leave | ||
CYTOSORBENTS | 0,884 | -4,54 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 5,240 | -100,00 % | TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy | ||
VOLITIONRX | 0,568 | -3,57 % | VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, May 16 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., May 15, 2025 /PRNewswire/... ► Artikel lesen | |
EKSO BIONICS | 0,257 | 0,00 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS03485P3001 Anglo American PLC 30.05.2025 US03485P4090 Anglo American PLC 02.06.2025 Tausch 10:8,807339US03815U5083 Applied... ► Artikel lesen | |
IMUNON | 1,340 | +1,52 % | IMNN-001 shows promise in ovarian cancer treatment | ||
BEYOND AIR | 0,158 | -1,86 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
NOVACYT | 0,552 | +0,36 % | Novacyt S.A. - Liquidity Agreement and Total Voting Rights | ||
AROVELLA THERAPEUTICS | 0,039 | 0,00 % | XFRA E4NA: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |